← Back to headlines
Citigroup Reduces Bio-Rad Laboratories Price Target to $300
Citigroup has lowered its price target for Bio-Rad Laboratories, Inc. (BIO) to $300, citing concerns related to the company's process chromatography segment.
24 Apr, 13:45 — 24 Apr, 13:45
Sources
Showing 1 of 1 sources
